Icecure Medical (ICCM) stock price

Icecure Medical (ICCM) is a Healthcare · Medical Devices company listed on NASDAQ. Price $1.96 (-1.51%), Market cap $0.02B, 52-week low–high $0.22 ~ $1.19.

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a m

Key metrics

• Price: $1.96 (-1.51%)
• Market cap: $0.02B
• 52-week low–high: $0.22 ~ $1.19
• Sector: Healthcare
• Industry: Medical Devices
• Exchange: NASDAQ

Financial statements, price targets, institutional (13F) holdings and related news for Icecure Medical are updated in real time on BlackAll Trade.

Icecure Medical financial summary

Analyst outlook

• Analyst consensus: 4.3333

Key ratios · profitability · growth

• P/B ratio: 2.15
• Profit margin: 0.00%
• Operating margin: -3.30%

Frequently asked questions